What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Chemotherapy
Mauricette Michallet focuses on Internal medicine, Surgery, Transplantation, Gastroenterology and Leukemia.
Many of her studies on Internal medicine involve topics that are commonly interrelated, such as Oncology.
Mauricette Michallet focuses mostly in the field of Surgery, narrowing it down to matters related to Multiple myeloma and, in some cases, Autologous transplantation, Survival rate and Dexamethasone.
Mauricette Michallet has included themes like Cyclophosphamide, Stem cell and Immunology in her Transplantation study.
Her Gastroenterology research is multidisciplinary, relying on both Busulfan, Cytarabine, Regimen, Chronic myelogenous leukemia and Hazard ratio.
The Leukemia study combines topics in areas such as Myeloid, Cancer research and Marrow transplantation.
Her most cited work include:
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma (795 citations)
- Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome (728 citations)
- Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia (486 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Internal medicine, Transplantation, Surgery, Gastroenterology and Oncology.
Her work in Hematopoietic stem cell transplantation, Myeloid leukemia, Cumulative incidence, Acute leukemia and Chemotherapy are all subfields of Internal medicine research.
Her Transplantation study combines topics from a wide range of disciplines, such as Regimen, Stem cell, Immunology and Fludarabine.
Her study explores the link between Surgery and topics such as Multiple myeloma that cross with problems in Dexamethasone.
Her Gastroenterology research incorporates elements of Progressive disease, Chronic myelogenous leukemia, Univariate analysis, Hazard ratio and Survival analysis.
When carried out as part of a general Oncology research project, her work on Autologous stem-cell transplantation is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
She most often published in these fields:
- Internal medicine (77.28%)
- Transplantation (48.73%)
- Surgery (42.60%)
What were the highlights of her more recent work (between 2015-2021)?
- Internal medicine (77.28%)
- Transplantation (48.73%)
- Hematopoietic stem cell transplantation (28.70%)
In recent papers she was focusing on the following fields of study:
Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Oncology and Myeloid leukemia are her primary areas of study.
The concepts of her Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
Her work carried out in the field of Transplantation brings together such families of science as Stem cell, Cell therapy, Incidence and Chronic lymphocytic leukemia.
Mauricette Michallet interconnects Survival rate, Regimen, Immunology, Histocompatibility and Fludarabine in the investigation of issues within Hematopoietic stem cell transplantation.
In general Oncology study, her work on Autologous stem-cell transplantation often relates to the realm of In patient, thereby connecting several areas of interest.
Her Myeloid leukemia study combines topics in areas such as Myeloid and Leukemia.
Between 2015 and 2021, her most popular works were:
- Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (48 citations)
- Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1. (46 citations)
- Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD. (44 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Chemotherapy
Mauricette Michallet mostly deals with Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Myeloid leukemia and Surgery.
Her biological study spans a wide range of topics, including Gastroenterology and Oncology.
She combines subjects such as Leukemia, Survival analysis and Hazard ratio with her study of Transplantation.
The various areas that Mauricette Michallet examines in her Hematopoietic stem cell transplantation study include Survival rate, Immunology, Histocompatibility and Chemoimmunotherapy.
Her studies in Myeloid leukemia integrate themes in fields like Myeloid, Stem cell, Cord Blood Stem Cell Transplantation and Bone marrow.
Mauricette Michallet interconnects Creatinine and Adverse effect in the investigation of issues within Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
